Exact Mass: 318.1995

Exact Mass Matches: 318.1995

Found 86 metabolites which its exact mass value is equals to given mass value 318.1995, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Menthyl pyrrolidone carboxylate

(2R,3S,4S,5R,6R)-2-(hydroxymethyl)-6-{[(1R,2S,5R)-5-methyl-2-(propan-2-yl)cyclohexyl]oxy}oxane-3,4,5-triol

C16H30O6 (318.2042)


1-menthyl-beta-d-glucoside, also known as (-)-menthyl o-β-glucopyranoside, is a member of the class of compounds known as terpene glycosides. Terpene glycosides are prenol lipids containing a carbohydrate moiety glycosidically bound to a terpene backbone. Thus, 1-menthyl-beta-d-glucoside is considered to be an isoprenoid lipid molecule. 1-menthyl-beta-d-glucoside is soluble (in water) and a very weakly acidic compound (based on its pKa). 1-menthyl-beta-d-glucoside can be found in peppermint, which makes 1-menthyl-beta-d-glucoside a potential biomarker for the consumption of this food product. Menthyl pyrrolidone carboxylate is used as a food additive [EAFUS] ("EAFUS: Everything Added to Food in the United States. [http://www.eafus.com/]")

   

(+)-neomenthyl beta-D-glucoside

(+)-neomenthyl beta-D-glucoside

C16H30O6 (318.2042)


   

tert-Butyl (2-(2-(2-(2-azidoethoxy)ethoxy)ethoxy)ethyl)carbamate

tert-Butyl (2-(2-(2-(2-azidoethoxy)ethoxy)ethoxy)ethyl)carbamate

C13H26N4O5 (318.1903)


   

L-Citronellol glucoside

2-[(3,7-dimethyloct-6-en-1-yl)oxy]-6-(hydroxymethyl)oxane-3,4,5-triol

C16H30O6 (318.2042)


L-Citronellol glucoside is found in alcoholic beverages. L-Citronellol glucoside is a constituent of wine grapes (Vitis vinifera) Constituent of wine grapes (Vitis vinifera). D-Citronellol glucoside is found in alcoholic beverages and fruits.

   

Glycopyrrolate

Pyrrolidinium, 3-((cyclopentylhydroxyphenylacetyl)oxy)-1,1-dimethyl-, bromide

C19H28NO3+ (318.2069)


Glycopyrrolate is only found in individuals that have used or taken this drug. It is a synthetic anticholinergic agent with a quaternary ammonium structure. A muscarinic competitive antagonist used as an antispasmodic, in some disorders of the gastrointestinal tract, and to reduce salivation with some anesthetics. [PubChem]Glycopyrrolate binds competitively to the muscarinic acetylcholine receptor. Like other anticholinergic (antimuscarinic) agents, it inhibits the action of acetylcholine on structures innervated by postganglionic cholinergic nerves and on smooth muscles that respond to acetylcholine but lack cholinergic innervation. These peripheral cholinergic receptors are present in the autonomic effector cells of smooth muscle, cardiac muscle, the sinoatrial node, the atrioventricular node, exocrine glands and, to a limited degree, in the autonomic ganglia. Thus, it diminishes the volume and free acidity of gastric secretions and controls excessive pharyngeal, tracheal, and bronchial secretions. D - Dermatologicals > D11 - Other dermatological preparations > D11A - Other dermatological preparations > D11AA - Antihidrotics D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018680 - Cholinergic Antagonists D002491 - Central Nervous System Agents

   

5-Hydroxyemedastine

1-(2-ethoxyethyl)-2-(4-methyl-1,4-diazepan-1-yl)-1H-1,3-benzodiazol-5-ol

C17H26N4O2 (318.2056)


5-Hydroxyemedastine is a metabolite of emedastine. Emedastine difumarate (Emadine) is a second generation antihistamine used in eye drops to treat allergic conjunctivitis. Its mechanism of action is a H1 receptor antagonist. (Wikipedia)

   

6-Hydroxyemedastine

1-(2-ethoxyethyl)-2-(4-methyl-1,4-diazepan-1-yl)-1H-1,3-benzodiazol-6-ol

C17H26N4O2 (318.2056)


6-Hydroxyemedastine is a metabolite of emedastine. Emedastine difumarate (Emadine) is a second generation antihistamine used in eye drops to treat allergic conjunctivitis. Its mechanism of action is a H1 receptor antagonist. (Wikipedia)

   

Secoisoodorinol

Secoisoodorinol

C18H26N2O3 (318.1943)


   
   
   

SCHEMBL9249136

SCHEMBL9249136

C16H30O6 (318.2042)


   
   

heliconol B

heliconol B

C16H30O6 (318.2042)


   

secuamamine F|secuamamine G

secuamamine F|secuamamine G

C18H26N2O3 (318.1943)


   

threonylalanyllysine

threonylalanyllysine

C13H26N4O5 (318.1903)


   

alanylthreonyllysine

alanylthreonyllysine

C13H26N4O5 (318.1903)


   
   
   
   
   

h_174_fluoxymesterone_m2

h_174_fluoxymesterone_m2

C20H27FO2 (318.1995)


   
   
   

L-Citronellol glucoside

2-[(3,7-dimethyloct-6-en-1-yl)oxy]-6-(hydroxymethyl)oxane-3,4,5-triol

C16H30O6 (318.2042)


   

ascr#16

9R-(3R,5R-dihydroxy-6S-methyl-(2H)-tetrahydropyran-2-yloxy)-decanoic acid

C16H30O6 (318.2042)


An (omega-1)-hydroxy fatty acid ascaroside obtained by formal condensation of the alcoholic hydroxy group of (9R)-9-hydroxydecanoic acid with ascarylopyranose (the alpha anomer). It is a metabolite of the nematode Caenorhabditis elegans.

   

oscr#16

10-(3R,5R-dihydroxy-6S-methyl-(2H)-tetrahydropyran-2-yloxy)-decanoic acid

C16H30O6 (318.2042)


An omega-hydroxy fatty acid ascaroside obtained by formal condensation of the alcoholic hydroxy group of 10-hydroxydecanoic acid with ascarylopyranose (the alpha anomer). It is a metabolite of the nematode Caenorhabditis elegans.

   

(-)-menthyl beta-D-glucoside

(-)-Menthyl O-beta-D-glucoside;(-)-menthyl O-beta-D-glucoside;(-)-menthyl O-beta-glucopyranoside

C16H30O6 (318.2042)


   

d-Neomenthyl glucoside

Neomenthyl-beta-D-glucoside

C16H30O6 (318.2042)


   

1-N-BOC-4-(4-METHYLCARBAMOYLPHENYL)PIPERIDINE

1-N-BOC-4-(4-METHYLCARBAMOYLPHENYL)PIPERIDINE

C18H26N2O3 (318.1943)


   
   

1-Bromoheptadecane

1-Bromoheptadecane

C17H35Br (318.1922)


   

6-AMINO-3-DIETHYLAMINOMETHYL-INDAZOLE-1-CARBOXYLIC ACID TERT-BUTYL ESTER

6-AMINO-3-DIETHYLAMINOMETHYL-INDAZOLE-1-CARBOXYLIC ACID TERT-BUTYL ESTER

C17H26N4O2 (318.2056)


   

tert-butyl 4-(oxiran-2-ylmethyl)-3-phenylpiperazine-1-carboxylate

tert-butyl 4-(oxiran-2-ylmethyl)-3-phenylpiperazine-1-carboxylate

C18H26N2O3 (318.1943)


   

cyclohexano-18-crown-6

cyclohexano-18-crown-6

C16H30O6 (318.2042)


   

1-Bromo-2-methylhexadecane

1-Bromo-2-methylhexadecane

C17H35Br (318.1922)


   

4-Fluoro-2-methyl-1-(1-methylethyl)-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-benzimidazole

4-Fluoro-2-methyl-1-(1-methylethyl)-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-benzimidazole

C17H24BFN2O2 (318.1915)


   

potassium linoleate

potassium linoleate

C18H31KO2 (318.1961)


   

spermine phosphate hexahydrate

spermine phosphate hexahydrate

C10H31N4O5P (318.2032)


   
   

Carbamic acid,N-[[(2-aminoethoxy)amino][[(1,1-dimethylethoxy)carbonyl]amino]methylene]-,1,1-dimethylethyl ester, hydrochloride (1:1)

Carbamic acid,N-[[(2-aminoethoxy)amino][[(1,1-dimethylethoxy)carbonyl]amino]methylene]-,1,1-dimethylethyl ester, hydrochloride (1:1)

C13H26N4O5 (318.1903)


   

1-BOC-4-ACETAMIDO-4-PHENYLPIPERIDINE

1-BOC-4-ACETAMIDO-4-PHENYLPIPERIDINE

C18H26N2O3 (318.1943)


   
   

(9R)-9-[(3,6-dideoxy-alpha-L-arabino-hexopyranosyl)oxy]decanoic acid

(9R)-9-[(3,6-dideoxy-alpha-L-arabino-hexopyranosyl)oxy]decanoic acid

C16H30O6 (318.2042)


   

10-[(3,6-dideoxy-alpha-L-arabino-hexopyranosyl)oxy]decanoic acid

10-[(3,6-dideoxy-alpha-L-arabino-hexopyranosyl)oxy]decanoic acid

C16H30O6 (318.2042)


   

Glycopyrronium

Glycopyrronium

C19H28NO3+ (318.2069)


C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent

   

Pyrrolidinium, 3-(((2S)-cyclopentylhydroxyphenylacetyl)oxy)-1,1-dimethyl-, (3R)-

Pyrrolidinium, 3-(((2S)-cyclopentylhydroxyphenylacetyl)oxy)-1,1-dimethyl-, (3R)-

C19H28NO3+ (318.2069)


   

[2-(Cycloheptylamino)-2-oxoethyl] 4-(dimethylamino)benzoate

[2-(Cycloheptylamino)-2-oxoethyl] 4-(dimethylamino)benzoate

C18H26N2O3 (318.1943)


   

L-Threonyl-L-alanyl-L-lysine

L-Threonyl-L-alanyl-L-lysine

C13H26N4O5 (318.1903)


   

Glycopyrronium bromide

Glycopyrronium bromide

C19H28NO3+ (318.2069)


D - Dermatologicals > D11 - Other dermatological preparations > D11A - Other dermatological preparations > D11AA - Antihidrotics D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018680 - Cholinergic Antagonists D002491 - Central Nervous System Agents

   

2-[(11bS)-3-ethyl-9,10-dimethoxy-1,2,3,4,5,6,7,11b-octahydrobenzo[a]quinolizin-5-ium-2-yl]acetaldehyde

2-[(11bS)-3-ethyl-9,10-dimethoxy-1,2,3,4,5,6,7,11b-octahydrobenzo[a]quinolizin-5-ium-2-yl]acetaldehyde

C19H28NO3+ (318.2069)


   

[3-Carboxy-1-(7-carboxyheptanoyloxy)propyl]-trimethylazanium

[3-Carboxy-1-(7-carboxyheptanoyloxy)propyl]-trimethylazanium

C15H28NO6+ (318.1917)


   

[3-Carboxy-2-(7-carboxyheptanoyloxy)propyl]-trimethylazanium

[3-Carboxy-2-(7-carboxyheptanoyloxy)propyl]-trimethylazanium

C15H28NO6+ (318.1917)


   

[3-Carboxy-2-(6-carboxy-3-methylhexanoyl)oxypropyl]-trimethylazanium

[3-Carboxy-2-(6-carboxy-3-methylhexanoyl)oxypropyl]-trimethylazanium

C15H28NO6+ (318.1917)


   

[3-Carboxy-2-(5-carboxy-3-methylhexanoyl)oxypropyl]-trimethylazanium

[3-Carboxy-2-(5-carboxy-3-methylhexanoyl)oxypropyl]-trimethylazanium

C15H28NO6+ (318.1917)


   

N-[2-[1-(3,5-dimethyl-1-piperidinyl)-1-oxopropan-2-yl]oxyphenyl]acetamide

N-[2-[1-(3,5-dimethyl-1-piperidinyl)-1-oxopropan-2-yl]oxyphenyl]acetamide

C18H26N2O3 (318.1943)


   

2-(5-methyl-4,5,6,7-tetrahydroindazol-2-yl)-N-[3-(2-oxo-1-pyrrolidinyl)propyl]acetamide

2-(5-methyl-4,5,6,7-tetrahydroindazol-2-yl)-N-[3-(2-oxo-1-pyrrolidinyl)propyl]acetamide

C17H26N4O2 (318.2056)


   

5-[(2-Methylphenoxy)methyl]-3-[(4-methyl-1-piperidinyl)methyl]-2-oxazolidinone

5-[(2-Methylphenoxy)methyl]-3-[(4-methyl-1-piperidinyl)methyl]-2-oxazolidinone

C18H26N2O3 (318.1943)


   

(2S)-4-methyl-2-[[oxo-(1,2,3,4-tetrahydronaphthalen-1-ylamino)methyl]amino]pentanoic acid methyl ester

(2S)-4-methyl-2-[[oxo-(1,2,3,4-tetrahydronaphthalen-1-ylamino)methyl]amino]pentanoic acid methyl ester

C18H26N2O3 (318.1943)


   

aculene B cation

aculene B cation

C19H28NO3+ (318.2069)


   
   
   
   
   
   

(9R)-9-fluoro-11-hydroxy-10,17,17-trimethyl-2,6,7,8,11,12,15,16-octahydro-1H-cyclopenta[a]phenanthren-3-one

(9R)-9-fluoro-11-hydroxy-10,17,17-trimethyl-2,6,7,8,11,12,15,16-octahydro-1H-cyclopenta[a]phenanthren-3-one

C20H27FO2 (318.1995)


   

[(2R)-3-carboxy-2-(7-carboxyheptanoyloxy)propyl]-trimethylazanium

[(2R)-3-carboxy-2-(7-carboxyheptanoyloxy)propyl]-trimethylazanium

C15H28NO6+ (318.1917)


   

9alpha-Fluoro-18-nor-17,17-dimethylandrosta-4,13-dien-11beta-ol-3-one

9alpha-Fluoro-18-nor-17,17-dimethylandrosta-4,13-dien-11beta-ol-3-one

C20H27FO2 (318.1995)


   

(-)-Menthyl O-beta-D-glucoside

(-)-Menthyl O-beta-D-glucoside

C16H30O6 (318.2042)


   

5-Hydroxyemedastine

5-Hydroxyemedastine

C17H26N4O2 (318.2056)


   

6-Hydroxyemedastine

6-Hydroxyemedastine

C17H26N4O2 (318.2056)


   

aculene B(1+)

aculene B(1+)

C19H28NO3 (318.2069)


A secondary ammonium ion that is the conjugate acid of aculene B, arising from the protonation of the pyrrolidine nitrogen. Major species at pH 7.3.

   
   

Menthyl beta-D-glucoside

Menthyl beta-D-glucoside

C16H30O6 (318.2042)


   

(1s,2s,8r,15r)-15-hydroxy-11-[(2s)-piperidin-2-yl]-13-oxa-7-azatetracyclo[6.5.2.0¹,¹⁰.0²,⁷]pentadec-10-en-12-one

(1s,2s,8r,15r)-15-hydroxy-11-[(2s)-piperidin-2-yl]-13-oxa-7-azatetracyclo[6.5.2.0¹,¹⁰.0²,⁷]pentadec-10-en-12-one

C18H26N2O3 (318.1943)


   

n-{4-[(2e)-3,7-dimethylocta-2,6-dien-1-yl]-2-(methoxycarbonyl)-1h-pyrrol-3-yl}ethanimidic acid

n-{4-[(2e)-3,7-dimethylocta-2,6-dien-1-yl]-2-(methoxycarbonyl)-1h-pyrrol-3-yl}ethanimidic acid

C18H26N2O3 (318.1943)


   

(2r,3r,3as,4s,6ar)-2-(9-hydroxynonyl)-tetrahydro-2h-cyclopenta[b]furan-3,3a,4,6a-tetrol

(2r,3r,3as,4s,6ar)-2-(9-hydroxynonyl)-tetrahydro-2h-cyclopenta[b]furan-3,3a,4,6a-tetrol

C16H30O6 (318.2042)


   

(2s)-4-hydroxy-n-(4-{[(2e)-1-hydroxy-3-phenylprop-2-en-1-ylidene]amino}butyl)-2-methylbutanimidic acid

(2s)-4-hydroxy-n-(4-{[(2e)-1-hydroxy-3-phenylprop-2-en-1-ylidene]amino}butyl)-2-methylbutanimidic acid

C18H26N2O3 (318.1943)


   

tridec-2-yn-1-yl 4-fluorobenzoate

tridec-2-yn-1-yl 4-fluorobenzoate

C20H27FO2 (318.1995)


   

(2s)-3-methyl-2-(3-methyl-2-oxobutanamido)-n-(2-phenylethyl)butanimidic acid

(2s)-3-methyl-2-(3-methyl-2-oxobutanamido)-n-(2-phenylethyl)butanimidic acid

C18H26N2O3 (318.1943)


   

(2r)-4-hydroxy-n-(4-{[(2e)-1-hydroxy-3-phenylprop-2-en-1-ylidene]amino}butyl)-2-methylbutanimidic acid

(2r)-4-hydroxy-n-(4-{[(2e)-1-hydroxy-3-phenylprop-2-en-1-ylidene]amino}butyl)-2-methylbutanimidic acid

C18H26N2O3 (318.1943)


   

15-hydroxy-11-(piperidin-2-yl)-13-oxa-7-azatetracyclo[6.5.2.0¹,¹⁰.0²,⁷]pentadec-10-en-12-one

15-hydroxy-11-(piperidin-2-yl)-13-oxa-7-azatetracyclo[6.5.2.0¹,¹⁰.0²,⁷]pentadec-10-en-12-one

C18H26N2O3 (318.1943)


   

4-hydroxy-n-(4-{[(2e)-1-hydroxy-3-phenylprop-2-en-1-ylidene]amino}butyl)-2-methylbutanimidic acid

4-hydroxy-n-(4-{[(2e)-1-hydroxy-3-phenylprop-2-en-1-ylidene]amino}butyl)-2-methylbutanimidic acid

C18H26N2O3 (318.1943)


   

2-(9-hydroxynonyl)-tetrahydro-2h-cyclopenta[b]furan-3,3a,4,6a-tetrol

2-(9-hydroxynonyl)-tetrahydro-2h-cyclopenta[b]furan-3,3a,4,6a-tetrol

C16H30O6 (318.2042)


   

(2r,3r,4s,5s,6r)-2-{[(3s)-3,7-dimethyloct-6-en-1-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,3r,4s,5s,6r)-2-{[(3s)-3,7-dimethyloct-6-en-1-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C16H30O6 (318.2042)


   

n-[4-(3,7-dimethylocta-2,6-dien-1-yl)-2-(methoxycarbonyl)-1h-pyrrol-3-yl]ethanimidic acid

n-[4-(3,7-dimethylocta-2,6-dien-1-yl)-2-(methoxycarbonyl)-1h-pyrrol-3-yl]ethanimidic acid

C18H26N2O3 (318.1943)


   

4-hydroxy-n-{4-[(1-hydroxy-3-phenylprop-2-en-1-ylidene)amino]butyl}-2-methylbutanimidic acid

4-hydroxy-n-{4-[(1-hydroxy-3-phenylprop-2-en-1-ylidene)amino]butyl}-2-methylbutanimidic acid

C18H26N2O3 (318.1943)